A third (booster) dose of the inactivated SARS-CoV-2 vaccine elicits immunogenicity and T follicular helper cell responses in people living with HIV

INTRODUCTION: This study sought to explore the immunogenicity of a booster dose of an inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine in people living with human immunodeficiency virus (HIV) and identify the factors affecting the magnitude of anti-SARS-CoV-2 antibody...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Zhengchao, Lv, Songqin, Li, Qin, Xia, Yafei, Feng, Zaineng, Zhang, Haohong, Yang, Haihao, Wu, Zhao, Zou, Nanting, Mo, Qingyan, Gu, Qianlan, Ying, Sai, Wang, Xicheng, Qin, Dongdong, Wan, Chunping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690609/
https://www.ncbi.nlm.nih.gov/pubmed/38045691
http://dx.doi.org/10.3389/fimmu.2023.1264160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690609/
https://www.ncbi.nlm.nih.gov/pubmed/38045691
http://dx.doi.org/10.3389/fimmu.2023.1264160

Ejemplares similares